Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Shoulder Innovations
SI · NYSE · Surgical & Medical Instruments & Apparatus
Shoulder Innovations (SI) · oqro.io/stocks/SI · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Since the trade +36.0% · S&P 500 +4.2% · to Nov 20
The CEO of Shoulder Innovations paid $33K out of pocket for Shoulder Innovations shares. 2 other people at Shoulder Innovations bought some too, in the same month.
Since the trade +36.0% · S&P 500 +4.2% · to Nov 20
The CFO of Shoulder Innovations paid $30K out of pocket for Shoulder Innovations shares. 2 other people at Shoulder Innovations bought some too, in the same month.
Since the trade +36.0% · S&P 500 +4.2% · to Nov 20
A Shoulder Innovations director paid $15K out of pocket for Shoulder Innovations shares. 2 other people at Shoulder Innovations bought some too, in the same month. Shares held went up 8% with this purchase.
Since the trade +28.3% · S&P 500 +4.9% · to Nov 20
The CFO of Shoulder Innovations paid $25K out of pocket for Shoulder Innovations shares. 1 other person at Shoulder Innovations bought some too, in the same month.
Since the trade +41.4% · S&P 500 +10.9% · to Nov 20
A Shoulder Innovations director paid $4M out of pocket for Shoulder Innovations shares. 6 other people at Shoulder Innovations bought some too, in the same month. Shares held went up 17% with this purchase.
Since the trade +41.4% · S&P 500 +10.9% · to Nov 20
A Shoulder Innovations director paid $600K out of pocket for Shoulder Innovations shares. 6 other people at Shoulder Innovations bought some too, in the same month. Shares held went up 522% with this purchase.
Since the trade +41.4% · S&P 500 +10.9% · to Nov 20
A major shareholder of Shoulder Innovations paid $1.5M out of pocket for Shoulder Innovations shares. 6 other people at Shoulder Innovations bought some too, in the same month.
Since the trade +41.4% · S&P 500 +10.9% · to Nov 20
A Shoulder Innovations director paid $1.5M out of pocket for Shoulder Innovations shares. 6 other people at Shoulder Innovations bought some too, in the same month.
Since the trade +41.4% · S&P 500 +10.9% · to Nov 20
Shoulder Innovations's LLC, Reporting person paid $4M out of pocket for Shoulder Innovations shares. 6 other people at Shoulder Innovations bought some too, in the same month.
Since the trade +41.4% · S&P 500 +10.9% · to Nov 20
A Shoulder Innovations director paid $75K out of pocket for Shoulder Innovations shares. 6 other people at Shoulder Innovations bought some too, in the same month. Shares held went up 65% with this purchase.
Since the trade +41.4% · S&P 500 +10.9% · to Nov 20
The CFO of Shoulder Innovations paid $750 out of pocket for Shoulder Innovations shares. 6 other people at Shoulder Innovations bought some too, in the same month.
3 open-market purchases and 17 open-market sales by insiders of SI between Feb 8, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 5, 2026. The data provider lists the next release for Mar 8, 2027; that date may change.
PurchaseSale30 days before a release30 days after
Trades in the 30 days around each of the last earnings releases
Robert Joseph Ball, CEO & Executive Chairman, Sep 14, 2026, about $188K. Sold 39 days after the company's previous earnings release on 2026-08-06Form 4
Gilde Healthcare Holding B.V., Aug 26, 2026, about $27K. Sold 20 days after the company's previous earnings release on 2026-08-06Form 4
Gilde Healthcare Holding B.V., Aug 24, 2026, about $15K. Sold 18 days after the company's previous earnings release on 2026-08-06Form 4
Gilde Healthcare Holding B.V., Aug 21, 2026, about $464K. Sold 15 days after the company's previous earnings release on 2026-08-06Form 4
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies
Gilde Healthcare Holding B.V., Aug 20, 2026, about $88K. Sold 14 days after the company's previous earnings release on 2026-08-06
Matthew Fraser Ahearn, Chief Operating Officer, Aug 18, 2026, about $263K. Sold 12 days after the company's previous earnings release on 2026-08-06Form 4
Matthew Fraser Ahearn, Chief Operating Officer, Aug 18, 2026, about $34K. Sold 12 days after the company's previous earnings release on 2026-08-06Form 4
Matthew Fraser Ahearn, Chief Operating Officer, Aug 17, 2026, about $167K. Sold 11 days after the company's previous earnings release on 2026-08-06Form 4
Gilde Healthcare Holding B.V., Aug 6, 2026, about $47K. Sold on the day of the company's earnings release on 2026-08-06Form 4
Gilde Healthcare Holding B.V., Aug 5, 2026, about $166K. Sold 1 day before the company's next earnings release on 2026-08-06Form 4